1-17266814-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_016233.2(PADI3):c.504C>A(p.Asp168Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,613,864 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016233.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI3 | NM_016233.2 | c.504C>A | p.Asp168Glu | missense_variant | 5/16 | ENST00000375460.3 | NP_057317.2 | |
PADI3 | XM_011541571.3 | c.390C>A | p.Asp130Glu | missense_variant | 5/16 | XP_011539873.1 | ||
PADI3 | XM_011541572.3 | c.504C>A | p.Asp168Glu | missense_variant | 5/12 | XP_011539874.1 | ||
PADI3 | XM_017001463.2 | c.-34C>A | 5_prime_UTR_variant | 2/13 | XP_016856952.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI3 | ENST00000375460.3 | c.504C>A | p.Asp168Glu | missense_variant | 5/16 | 1 | NM_016233.2 | ENSP00000364609 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251304Hom.: 0 AF XY: 0.000464 AC XY: 63AN XY: 135816
GnomAD4 exome AF: 0.000167 AC: 244AN: 1461584Hom.: 2 Cov.: 31 AF XY: 0.000241 AC XY: 175AN XY: 727102
GnomAD4 genome AF: 0.000125 AC: 19AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74454
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2022 | The c.504C>A (p.D168E) alteration is located in exon 5 (coding exon 5) of the PADI3 gene. This alteration results from a C to A substitution at nucleotide position 504, causing the aspartic acid (D) at amino acid position 168 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at